Subscribe to RSS
Download PDF
DOI: 10.1055/a-1220-6389
Diagnostic limitations of magnifying endoscopy with narrow-band imaging in early gastric cancer
Abstract
Background and study aims Magnifying endoscopy with narrow band imaging (M-NBI) has made a huge contribution to endoscopic diagnosis of early gastric cancer (EGC). However, we sometimes encountered false-negative cases with M-NBI diagnosis (i. e., M-NBI diagnostic limitation lesion: M-NBI-DLL). However, clinicopathological features of M-NBI-DLLs have not been well elucidated. We aimed to clarify the clinicopathological features and histological reasons of M-NBI-DLLs.
Patients and methods In this single-center retrospective study, M-NBI-DLLs were extracted from 456 EGCs resected endoscopically at our hospital. We defined histological types of M-NBI-DLLs and analyzed clinicopathologically to clarify histological reasons of M-NBI-DLLs.
Results Of 456 EGCs, 48 lesions (10.5 %) of M-NBI-DLLs were enrolled. M-NBI-DLLs was classified into four histological types as follows: gastric adenocarcinoma of fundic-gland type (GA-FG, n = 25), gastric adenocarcinoma of fundic-gland mucosal type (GA-FGM, n = 1), differentiated adenocarcinoma (n = 14), and undifferentiated adenocarcinoma (n = 8). Thirty-nine lesions of M-NBI-DLLs were H. pylori-negative gastric cancers (39/47, 82.9 %). Histological reasons for M-NBI-DLLs were as follows: 1) completely covered with non-neoplastic mucosa (25/25 GA-FG, 8/8 undifferentiated adenocarcinoma); 2) well-differentiated adenocarcinoma with low-grade atypia (1/1 GA-FGM, 14/14 differentiated adenocarcinoma); 3) similarity of surface structure (10/14 differentiated adenocarcinoma); and 4) partially covered and/or mixed with a non-neoplastic mucosa (1/1 GA-FGM, 6/14 differentiated adenocarcinoma).
Conclusions Diagnostic limitations of M-NBI depend on four distinct histological characteristics. For accurate diagnosis of M-NBI-DLLs, it may be necessary to fully understand endoscopic features of these lesions using white light imaging and M-NBI based on these histological characteristics and to take a precise biopsy.
Publication History
Received: 19 February 2020
Accepted: 08 May 2020
Article published online:
21 September 2020
© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Kaltenbach T, Sano Y, Friedland S. et al. American Gastroenterological Association (AGA) Institute technology assessment on image-enhanced endoscopy. Gastroenterology 2008; 134: 327-340
- 2 Muto M, Yao K, Kaise M. et al. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G). Dig Endosc 2016; 28: 379-393
- 3 Ezoe Y, Muto M, Horimatsu T. et al. Magnifying narrow-band imaging versus magnifying white-light imaging for the differential diagnosis of gastric small depressive lesions: a prospective study. Gastrointest Endosc 2010; 71: 477-484
- 4 Ezoe Y, Muto M, Uedo N. et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology 2011; 141: 2017-2025.e2013
- 5 Morita Y, Fujiwara S, Tanaka S. et al. A case of small early gastric cancer that was successfully detected by narrow band imaging magnifying endoscopy. Dig Endosc 2011; 23: 89-91
- 6 Nagahama T, Yao K, Maki S. et al. Usefulness of magnifying endoscopy with narrow-band imaging for determining the horizontal extent of early gastric cancer when there is an unclear margin by chromoendoscopy (with video). Gastrointest Endosc 2011; 74: 1259-1267
- 7 Miwa K, Doyama H, Ito R. et al. Can magnifying endoscopy with narrow band imaging be useful for low grade adenomas in preoperative biopsy specimens?. Gastric Cancer 2012; 15: 170-178
- 8 Tsuji Y, Ohata K, Sekiguchi M. et al. Magnifying endoscopy with narrow-band imaging helps determine the management of gastric adenomas. Gastric Cancer 2012; 15: 414-418
- 9 Maki S, Yao K, Nagahama T. et al. Magnifying endoscopy with narrow-band imaging is useful in the differential diagnosis between low-grade adenoma and early cancer of superficial elevated gastric lesions. Gastric Cancer 2013; 16: 140-146
- 10 Yao K, Nagahama T, Matsui T. et al. Detection and characterization of early gastric cancer for curative endoscopic submucosal dissection. Dig Endosc 2013; 25: 44-54
- 11 Hwang JW, Bae YS, Kang MS. et al. Predicting pre- and post-resectional histologic discrepancies in gastric low-grade dysplasia: A comparison of white-light and magnifying endoscopy. J Gastroenterol Hepatol 2016; 31: 394-402
- 12 Nonaka T, Inamori M, Honda Y. et al. Can magnifying endoscopy with narrow-band imaging discriminate between carcinomas and low grade adenomas in gastric superficial elevated lesions?. Endosc Int Open 2016; 4: E1203-e1210
- 13 Yoshimizu S, Yamamoto Y, Horiuchi Y. et al. Diagnostic performance of routine esophagogastroduodenoscopy using magnifying endoscope with narrow-band imaging for gastric cancer. Dig Endosc 2018; 30: 71-78
- 14 Ueyama H, Yao T, Nakashima Y. et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol 2010; 34: 609-619
- 15 WHO Classification of Tumours Editorial Board. WHO Classification of Tumours. 5th ed, Vol 1 Digestive System tumours. Lyon: IARC; 2019
- 16 Ueyama H, Yao T, Matsumoto K. et al. Establishment of endoscopic diagnosis for gastric adenocarcinoma of fundic gland type (chief cell predominant type) usingmagnifying endoscopy with narrow-band imaging. 50. Tokyo: Stomach Intestine; 2015: 1533-1547
- 17 Fujiwara S, Yao K, Imamura K. et al. M-NBI findings of gastric adenocarcinoma offundic gland type and adenocarcinoma with differentiation towards the fundic mucosa. 50. Tokyo: Stomach Intestine; 2015: 1548-1558
- 18 Ueyama H, Yao T, Nagahara A. et al. Gastric Adenocarcinoma of fundic gland type. 53. Tokyo: Stomach Intestine; 2018: 753-767
- 19 Yoshimura D, Yoshimura R, Kato S. et al. Characteristics of gastric cancer without Helicobacter pylori Infection and its relation to background mucosa. 53. Tokyo: Stomach Intestine; 2018: 658-670
- 20 Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy 2009; 41: 462-467
- 21 Kimura K. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97
- 22 Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002; 51: 130-131
- 23 Nihon Igan G. Igan toriatsukai kiyaku. Tokyo: Kaneharashuppan; 2017
- 24 Yao K, Doyama H, Gotoda T. et al. Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study. Gastric Cancer 2014; 17: 669-679
- 25 Fujisaki J, Horiuchi Y, Yamamoto N. et al. Characteristic findings of difficult cases to diagnose using ME-NBI. Stomach Intestine (Tokyo) 2015; 50: 279-288
- 26 Yao K, Nagahama T, Maki S. et al. Usefulness of magnifying endoscopy with Narrow-band imaging for determining the margins of superficial flat Type (0 IIb) of early gastric carcinomas. Stomach Intestine (Tokyo) 2010; 45: 86-100
- 27 Yao K, Fujiwara S, Nagahama T. et al. Diagnostic performance and limitations ofmagnifying narrow-band imaging for the diagnosis of minute gastric cancer. Stomach Intestine (Tokyo) 2013; 48: 843-856
- 28 Nagahama T, Imamura K, Kojima T. et al. Usefulness and limitations of the magnifying endoscopy with narrow band imaging for delineation of very well diff erentiated adenocarcinoma of the stomach. Stomach Intestine (Tokyo) 2015; 50: 267-278
- 29 Okada K, Fujisaki J, Kasuga A. et al. Diagnosis of undifferentiated type early gastric cancers by magnification endoscopy with narrow-band imaging. J Gastroenterol Hepatol 2011; 26: 1262-1269
- 30 Ito M, Tanaka S, Takata S. et al. Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther 2005; 21: 559-566
- 31 Kobayashi M, Hashimoto S, Nishikura K. et al. Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication. J Gastroenterol 2013; 48: 1332-1342
- 32 Kitamura Y, Ito M, Matsuo T. et al. Characteristic epithelium with low-grade atypia appears on the surface of gastric cancer after successful Helicobacter pylori eradication therapy. Helicobacter 2014; 19: 289-295
- 33 Saka A, Yagi K, Nimura S. Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy. Gastric Cancer 2016; 19: 524-530
- 34 Kamada T, Haruma K, Ito M. et al. Time trends in Helicobacter pylori infection and atrophic gastritis over 40 years in Japan. Helicobacter 2015; 20: 192-198